![](https://investorshub.advfn.com/uicon/691940.png?cb=1578604518)
Thursday, March 28, 2024 7:31:31 AM
Submission received: 25 February 2024 / Revised: 22 March 2024 / Accepted: 25 March 2024 / Published: 28 March 2024
In a randomized controlled trial by Bagnato et al., utilizing the Bioelectronics Corporation’s PEMF device for 12 h daily over one month in knee osteoarthritis patients, a significant reduction in pain intensity emerged as the primary outcome [27]. This improvement was coupled with enhancements in quality of life and an increased pain threshold in response to pressure.
https://www.mdpi.com/2077-0383/13/7/1959
Do your own due diligence when investing. My posts are my opinion!!
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM